Co-administration of a chicken interleukin-2-interferon-α fusion protein enhances immune responses and protective efficacy of an inactivated fowl adenovirus serotype 4 vaccine.
Findings support further evaluation of chIL2-IFNα as an immunostimulant for inactivated FAdV-4 vaccines.